title: Tunicamycin-resistant variants from five species of Leishmania contain amplified DNA in extrachromosomal circles of different sizes with a transcriptionally active homologous region.
abstract: Twelve independent variants were selected from five species of Leishmania for resistance to tunicamycin by exposure of cultured promastigotes to increasing concentrations of this antibiotic, an inhibitor of the microsomal N-acetylglucosamine-1-phosphate transferase in the dolichol pathway of N-glycosylation. All variants obtained from all species, as found previously with Leishmania amazonensis, contain amplified chromosomal DNA exclusively as extrachromosomal circles. These circular amplicons hybridize with amplified DNAs cloned previously from tunicamycin-resistant Leishmania amazonensis, but not with those from Leishmania resistant to other drugs. The amplicons from tunicamycin-resistant cells vary with different species in size from 30 to 70 kb, but all share a homologous region of 20 kb. Multiple independent transcripts are overexpressed from this region. Elevation of the microsomal glycosyltransferase activity is demonstrated in these variants from representative species. The results thus provide further evidence that this enzyme is overexpressed due to amplification of the gene in these cells. The consistent observation of this event in all cases studied also suggests that this is the predominant, if not the only mechanism of tunicamycin resistance in Leishmania.
authors.affiliation: Department of Microbiology and Immunology, University of Health Sciences, Chicago Medical School, IL 60064.
authors.forename: K
authors.initials: K
authors.lastname: Katakura
authors.forename: Y
authors.initials: Y
authors.lastname: Peng
authors.forename: R
authors.initials: R
authors.lastname: Pithawalla
authors.forename: S
authors.initials: S
authors.lastname: Detke
authors.forename: K P
authors.initials: KP
authors.lastname: Chang
mesh_terms: D000818:Animals; D015152:Blotting, Northern; D004270:DNA, Circular / Q000235:genetics* / Q000648:ultrastructure; D016054:DNA, Protozoan / Q000235:genetics* / Q000648:ultrastructure; D004351:Drug Resistance / Q000235:genetics; D005784:Gene Amplification; D015870:Gene Expression; D007891:Leishmania / Q000187:drug effects / Q000201:enzymology / Q000235:genetics* / Q000648:ultrastructure; D010770:Phosphotransferases / Q000235:genetics / Q000378:metabolism; D015183:Restriction Mapping; D012689:Sequence Homology, Nucleic Acid; D013045:Species Specificity; D014158:Transcription, Genetic; D017855:Transferases (Other Substituted Phosphate Groups); D014415:Tunicamycin / Q000494:pharmacology*
chemical_list: D004270:DNA, Circular; D016054:DNA, Protozoan; D014415:Tunicamycin; D010770:Phosphotransferases; D017855:Transferases (Other Substituted Phosphate Groups); C023222:UDPacetylglucosamine-dolichyl-phosphate acetylglucosamine-1-phosphate transferase